期刊文献+

软骨肉瘤与骨肉瘤免疫组化研究 被引量:1

An Immunohistochemical Study of Chon-drosarcomas and Osteosarcomas
原文传递
导出
摘要 应用免疫组化方法对36例各亚型软骨肉瘤、骨肉瘤以及骨Ewing氏瘤、淋巴瘤各5例,进行了S-100蛋白(S-100)波形蛋白(virnentin,Vim)、α_1-抗胰糜蛋白酶(alpha1-antichymotrypsin,AACT)、溶菌酶(lysozyme,Lyso)、白细胞共同抗原(leucocytecommonantigen,LCA)、Leu7、osteonectin(ON)、NSE等八种免疫抗血清的检测,结果发现,S-100、Lyso可以作为成软骨性肿瘤瘤细胞的标记物,ON可以作为骨细胞骨母细胞样分化的标记物之一。作者讨论了各亚型软骨肉瘤、骨肉瘤的组织发生学,也探讨了间叶性软骨肉瘤与骨的Ewing氏瘤、骨的淋巴瘤的鉴别诊断问题。 Abstract Immunohistochemical Studies were performed on 21chondrosarcomas and 1 5 osteosarcomas,includipg sub-types. Five Ewing,s tu mors and 5 lymphomas were alsosimilarly studied,The immunoreactivity of 46 tumors wasstudied using antlsera for S-100 proteln(S-100),vimentin( Vim ),alphW-1-antichymotrypsin(AACT),lysozyme(Lyso),leucocyte common antigen(LCA), leu 7,os-teonectin(ON)and NSE. Astrong reactivity for Vim wasf0und血tumO,cek0fch0ndroosarcomas, osteosarcomas and Ewing's tumors.Staining for S- 100,Lyso were consis-tently p‘Sitive in chondrocytes of chondrosarcomas and os-teosarcomas. S-100,Lyso seem to be a marker for tumorsof CartilagiOnous origin and differentiation,ON seems alsoto be a differentiation marker of osteoblasts.
出处 《中华骨科杂志》 CAS CSCD 北大核心 1994年第2期99-102,T002,共5页 Chinese Journal of Orthopaedics
  • 相关文献

参考文献3

共引文献3

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部